The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes , Diabetes Care , and Diabetologia Expert Forum
Diabetes Care · 01.10.2025 · 48 (10) · 1651-1667
DOI: 10.2337/dci25-0013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes Care, online erschienen am 30.07.2025. Verfasst von Carmella Evans-Molina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Novo Nordisk Foundation, NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This article summarizes the current understanding of the heterogeneity of type 1 diabetes from a June 2024 international Expert Forum organized by the editors of Diabetes, Diabetes Care, and Diabetologia. The Forum reviewed key factors contributing to the development and progression of type 1 diabetes and outlined specific, high-priority research questions. Knowledge gaps were identified, and, notably, opportunities to harness disease heterogeneity to develop personalized therapies were outlined. Herein, we summarize our discussions and review the heterogeneity of genetic risk and immunologic and metabolic phenotypes that influence and characterize type 1 diabetes progression (presented as a palette of risk factors). We discuss how these age-related factors determine disease aggressiveness (along gradients) and describe how variable immunogenetic pathways aggregate (into networks) to affect β-cell and other pancreatic pathologies to cause clinical disease at different ages and with variable severity (described as disease-related thresholds). Heterogeneity of pathogenesis and clinical severity opens avenues to prevention and intervention, including the potential of disease-modifying immunotherapy and islet cell replacement. We conclude with a call for 1) continued research to identify more factors contributing to the disease, both overall and in specific subgroups; 2) investigations focusing on both individuals who surpass metabolic and immune thresholds and develop diabetes and those who remain disease free with the same level of immunogenetic risk; and 3) efforts to identify where the current type 1 diabetes staging system may fall short and determine how it can be improved to capture and leverage heterogeneity in prevention and intervention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.
- Department of Pediatrics and the Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN.
- Richard L. Roudebush VA Medical Center, Indianapolis, IN.
- Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
- Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Malmö, Sweden.
- Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium.
ORCID-Profile: Carmella Evans-Molina, Yuval Dor, Åke Lernmark, Chantal Mathieu, Jeffrey R Millman, Raghavendra G Mirmira, Flemming Pociot, Maria J Redondo, Stephen S Rich, Sarah J Richardson, Michael R Rickels, R David Leslie
Förderung
- NIDDK NIH HHS
- Novo Nordisk Foundation
- NIH HHS
- BLRD VA
- NIH
Zitieren
APA
Evans-Molina, C., Dor, Y., Lernmark, Å., Mathieu, C., Millman, J. R., Mirmira, R. G., Pociot, F., Redondo, M. J., Rich, S. S., Richardson, S. J., Rickels, M. R., & Leslie, R. D. (2025). The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes , Diabetes Care , and Diabetologia Expert Forum. Diabetes Care, 48(10), 1651-1667. https://doi.org/10.2337/dci25-0013
Vancouver
Evans-Molina C, Dor Y, Lernmark Å, Mathieu C, Millman JR, Mirmira RG, et al. The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes , Diabetes Care , and Diabetologia Expert Forum. Diabetes Care. 2025;48(10):1651-1667. doi:10.2337/dci25-0013
BibTeX
@article{EvansMolina2025,
author = {Evans-Molina, Carmella and Dor, Yuval and Lernmark, Åke and Mathieu, Chantal and Millman, Jeffrey R and Mirmira, Raghavendra G and Pociot, Flemming and Redondo, Maria J and Rich, Stephen S and Richardson, Sarah J and Rickels, Michael R and Leslie, R David},
title = {The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes , Diabetes Care , and Diabetologia Expert Forum},
journal = {Diabetes Care},
year = {2025},
volume = {48},
number = {10},
pages = {1651--1667},
doi = {10.2337/dci25-0013}
}
EUVIMED